CAHILL FINANCIAL ADVISORS INC

Position in AMGN — Amgen Inc

CIK 1600327 EDINA, MN

Position in AMGN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$346,186

+$10,170 QoQ

Shares Held

956

+0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#2,454

of 3,139 holders

Holding Since

Dec 2023

6 quarters on record

Voting authority Sole 48% Shared 0% None 52%

Healthcare · as of Jun 30, 2026

CAHILL FINANCIAL ADVISORS INC holds $3,643,630 across 6 Drug Manufacturers - General names. AMGN ranks #5 (9.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,966	$1,261,215
2	ABBV	AbbVie Inc.	2,753	$692,764
3	MRK	Merck & Co., Inc.	4,446	$571,311
4	GILD	Gilead Sciences, Inc.	3,540	$447,243
5	AMGN	Amgen Inc This page	956	$346,186
6	PFE	Pfizer Inc	13,493	$324,911

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$346,186	956	+0.1%	Shares	Sole	2026-08-11
2026-03-31	$336,016	955	0.0%	Shares	Sole	2026-05-13
2025-12-31	$312,581	955	-9.7%	Shares	Sole	2026-02-18
2025-09-30	$298,567	1,058	+61.0%	Shares	Sole	2025-11-03
2025-03-31	$204,688	657	-37.1%	Shares	Sole	2025-05-15
2023-12-31	$300,980	1,045	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.